227467-79-0

Basic information

• Product Name: ethyl N-[4-[2-[[(1S, 2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]phenyl]-N-methylaminoacetate
• Synonyms: ethyl N-[4-[2-[[(1S, 2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]phenyl]-N-methylaminoacetate
• CAS NO: 227467-79-0
• Molecular Weight: 386.491
• Mol File: 227467-79-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: ethyl N-[4-[2-[[(1S, 2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]phenyl]-N-methylaminoacetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl N-[4-[2-[[(1S, 2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]phenyl]-N-methylaminoacetate(227467-79-0)
• EPA Substance Registry System: ethyl N-[4-[2-[[(1S, 2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]amino]ethyl]phenyl]-N-methylaminoacetate(227467-79-0)

Safety Data

• Hazardous Substances Data: 227467-79-0(Hazardous Substances Data)

Upstream product

• 552-85-2 4-((1R,2S)-2-amino-1-hydroxypropyl)phenol 
• 344285-72-9 ethyl N-[4-(2-bromoethyl)phenyl]-N-methylaminoacetate 
• 227467-47-2 ethyl N-[4-(2-hydroxyethyl)phenyl]aminoacetate 
• 104-10-9 2-(4'-aminophenyl)ethyl alcohol 
• 227467-55-2 ethyl N-[4-(2-hydroxyethyl)phenyl]-N-methylaminoacetate 

Relevant articles and documents

Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same

The present invention provides novel phenylaminoalkyl-carboxylic acid derivatives represented by the general formula: (wherein R1represents a hydroxy group, a lower alkoxy group, an aralkoxy group, an amino group, an alicyclic amino group or a mono or di(lower alkyl)amino group which may have a hydroxy group or a lower alkoxy group as a substituent; R2represents a hydrogen atom or a lower alkyl group; R3represents a hydrogen atom or a halogen atom; R4and R5are the same or different and each represents a hydrogen atom, a halogen atom or a lower alkyl group; A represents a lower alkylene group; the carbon atom marked with (R) represents a carbon atom in (R) configuration; and the carbon atom marked with (S) represents a carbon atom in (S) configuration) and pharmaceutically acceptable salts thereof, which have excellent β3-adrenoceptor stimulating effects and are useful as agents for the prevention or treatment of obesity, hyperglycemia, the diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression, or the diseases caused by biliary calculi or hypermotility of biliary tract.